ArticleBiomedical reports2025
Analysis of clinical features and risk factors of pulmonary hypertension associated with interstitial lung disease.
Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comorbidities' Effect on IPF: Pathogenesis and Management.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension (PH) can significantly impact the prognosis of interstitial lung disease (ILD). There are limited studies on the clinical characteristics and risk factors of PH associated with ILD (PH-ILD). The present study aimed to analyze the clinical characteristics of patients with PH-ILD and explore the correlation and predictive value of the easily obtainable indicators with respect to the severity of PH in patients with ILD. The results indicated that the red blood cell distribution width (RDW) and mean platelet volume (MPV) of patients with ILD with the moderate-to-severe PH (Ms-PH) were significantly higher compared with those of patients with ILD without PH and those with Mild-PH (P<0.05). Age, RDW, MPV and immunoglobulin G levels were emerged as independent risk factors for Ms-PH in patients with ILD. Receiver operating characteristic curve analysis demonstrated that the combination of RDW and MPV enhances the diagnostic efficiency for Ms-PH in patients with ILD. Consequently, the present study demonstrated that RDW and MPV are predictive factors for Ms-PH in patients with ILD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.